45 results
Polycystic Kidney Disease (PKD): cystic genetic disorder of kidneys, 2 types ADPKD & ARPKD - Temple
Disease (PKD): ... , 2 types ADPKD ... & ARPKD - Temple ... Clinical #POCUS #PKD ... #PCKD #RenalUS
Autosomal dominant PCKD with liver involvement on Renal Ultrasound
Multiple anechoic cysts seen in the kidney and
Autosomal dominant PCKD ... cysts seen in the kidney ... RJonesSonoEM #ADPKD ... #ADPCKD #Renal ... #kidney #cystic
Bilateral enlarged #kidney in a patient with #polycystic kidney disease

#PhysicalExam #clinical #video #PKD #ADPKD #nephrology
Bilateral enlarged #kidney ... with #polycystic kidney ... clinical #video #PKD ... #ADPKD #nephrology
Polycystic Kidney Disease - Clinical Signs and Symptoms

#ADPKD #Polycystic #Kidney #Disease #Signs #Symptoms #Diagnosis
Polycystic Kidney ... and Symptoms #ADPKD ... #Polycystic #Kidney
Definitions of AKI, CKD, AKD
Acute Kidney Injury (AKI):
 • Increase in SCr by 2 50% within
Definitions of AKI, CKD ... , AKD Acute Kidney ... Disease (CKD): ... /CKD • No structural ... damage #AKI #CKD
Algorithm for diagnostic evaluation of patients with kidney cysts and polycystic kidney disease

#polycystic #kidney #disease #cysts
patients with kidney ... and polycystic kidney ... #polycystic #kidney ... Algorithm #diagnosis #ADPKD
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
SGLT2i in HF and CKD ... lowered adverse kidney ... events in CKD + ... patients with CKD ... #CKD
REPRISE Trial - Tolvaptan in CKD - Visual Abstract

Does tolvaptan slow the progression of autosomal dominant
- Tolvaptan in CKD ... dominant polycystic kidney ... progression of CKD ... in ADPKD, It also ... REPRISE #Trial #CKD
Pathophysiology - Pathogenesis of Chronic Kidney Disease

#Pathophysiology #Nephrology #Chronic #Kidney #Disease #CKD
Pathogenesis of Chronic Kidney ... Nephrology #Chronic #Kidney ... #Disease #CKD
Chronic kidney disease 
#ckd #chronic_kidney_disease
Chronic kidney disease ... #ckd #chronic_kidney_disease